logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Taylor, Michael
    Born in November 1963
    Individual (3 offsprings)
    Officer
    2018-04-11 ~ now
    OF - Director → CIF 0
    Michael Taylor
    Born in November 1963
    Individual (3 offsprings)
    Person with significant control
    2018-04-11 ~ now
    PE - Has significant influence or controlCIF 0
parent relation
Company in focus

TRANSPHARM CLINICAL CONSULTING LTD

Period: 2018-04-11 ~ now
Company number: 11304280
Registered name
TRANSPHARM CLINICAL CONSULTING LTD - now
Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Property, Plant & Equipment
752 GBP2025-04-30
1,503 GBP2024-04-30
Debtors
8,951 GBP2025-04-30
725 GBP2024-04-30
Cash at bank and in hand
162,717 GBP2025-04-30
122,413 GBP2024-04-30
Current Assets
171,668 GBP2025-04-30
123,138 GBP2024-04-30
Net Current Assets/Liabilities
158,992 GBP2025-04-30
117,129 GBP2024-04-30
Total Assets Less Current Liabilities
159,744 GBP2025-04-30
118,632 GBP2024-04-30
Net Assets/Liabilities
159,601 GBP2025-04-30
118,346 GBP2024-04-30
Equity
Called up share capital
1 GBP2025-04-30
1 GBP2024-04-30
Retained earnings (accumulated losses)
159,600 GBP2025-04-30
118,345 GBP2024-04-30
Equity
159,601 GBP2025-04-30
118,346 GBP2024-04-30
Average Number of Employees
02024-05-01 ~ 2025-04-30
02023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
2,255 GBP2025-04-30
2,255 GBP2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
1,503 GBP2025-04-30
752 GBP2024-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
751 GBP2024-05-01 ~ 2025-04-30
Property, Plant & Equipment
Plant and equipment
752 GBP2025-04-30
1,503 GBP2024-04-30
Trade Debtors/Trade Receivables
8,860 GBP2025-04-30
600 GBP2024-04-30
Other Debtors
91 GBP2025-04-30
125 GBP2024-04-30
Taxation/Social Security Payable
Amounts falling due within one year
9,992 GBP2025-04-30
4,759 GBP2024-04-30
Other Creditors
Amounts falling due within one year
2,684 GBP2025-04-30
1,250 GBP2024-04-30

  • TRANSPHARM CLINICAL CONSULTING LTD
    Info
    Registered number 11304280
    International House, Cornhill, London EC3V 3NG
    PRIVATE LIMITED COMPANY incorporated on 2018-04-11 (7 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-10
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.